Table 2.
Univariate analysis of H3K27m3 expression and various clinicopathological parameters in 126 patients with UCB.
| Characteristic | Total cases | RR (95% CI) | P value |
|---|---|---|---|
| Age, years | 0.786 | ||
| ≤65* | 68 | 1 | |
| >65 | 58 | 1.090 (0.586–2.027) | |
| Gender | 0.675 | ||
| Male | 114 | 1 | |
| Female | 12 | 0.777 (0.239–2.523) | |
| Tumor multiplicity | 0.026 | ||
| Unifocal | 49 | 1 | |
| Multifocal | 77 | 2.025 (1.088–3.771) | |
| WHO grade | 0.330 | ||
| G1 | 24 | 1 | |
| G2 | 46 | 2.069 (0.757–5.655) | |
| G3 | 56 | 2.016 (0.751–5.412) | |
| pT status | <0.001 | ||
| PT1 | 25 | 1 | |
| PT2 | 55 | 1.047 (0.363–3.017) | |
| PT3 | 30 | 2.561 (0.908–7.219) | |
| PT4 | 16 | 6.577 (2.250–19.227) | |
| pN status | <0.001 | ||
| PN− | 105 | 1 | |
| PN+ | 21 | 4.957 (2.573–9.549) | |
| H3K27me3 | <0.001 | ||
| Low expression | 67 | 1 | |
| High expression | 59 | 6.476 (2.857–14.676) |
*Median age; RR: relative risk; CI: confidence interval; UCB: urothelial carcinoma of bladder.